Skip to main content

Kalia Kumud's Form 4 filing

Guardant Health, Inc. (GH) · filed Jun 30, 2026

Accession no.
0001927831-26-000018
Filed
Jun 30, 2026
Trade date
Jun 10-15, 2026
Filing delay
20 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market purchases total $78.5K. Open-market sales total $157.2K. It was filed 20 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kalia KumudCIK 0001927831Officer (Chief Information Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 10, 2026Common StockSSaleDisposed−600$130.86−$78,51640,814Direct
Jun 15, 2026Common StockPPurchaseAcquired+600$130.76+$78,45641,414Direct
Jun 15, 2026Common StockSSaleDisposed−600$131.08F1−$78,64840,814Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Based on the foregoing transactions, the Company identified recoverable Section 16(b) short-swing profits in the amount $192, which Mr. Kalia has paid to the Company.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)